Assembly Biosciences (NASDAQ:ASMB) reported quarterly losses of $(0.72) per share which beat the analyst consensus estimate of $(0.78) by 7.1 percent. This is a 52.32 percent increase over losses of $(1.51) per share from the same period last year. The company reported quarterly sales of $10.789 million which beat the analyst consensus estimate of $7.459 million by 44.64 percent. This is a 57.62 percent increase over sales of $6.845 million the same period last year.